Multiple Mutations in Hepatitis C Virus NS5A Domain II Are Required To Confer a Significant Level of Resistance to Alisporivir

Jose A. Garcia-Rivera(Naval Medical Research Command), Philippe Gallay(Scripps Research Institute), Matthew A. Gregory, Michael Bobardt(Scripps Research Institute), Kai Lin(US Biologic (United States)), Udayan Chatterji(Scripps Research Institute), Sam Hopkins(Scynexis (United States)), Barrie Wilkinson(Norwich Research Park)
Antimicrobial Agents and Chemotherapy
July 17, 2012
Cited by 42


Related Papers